RS50173B - Upotreba epinastina za lečenje alergijskog rinitisa/konjuktivitisa - Google Patents

Upotreba epinastina za lečenje alergijskog rinitisa/konjuktivitisa

Info

Publication number
RS50173B
RS50173B YUP-336/02A YUP33602A RS50173B RS 50173 B RS50173 B RS 50173B YU P33602 A YUP33602 A YU P33602A RS 50173 B RS50173 B RS 50173B
Authority
RS
Serbia
Prior art keywords
optionally
conjunctivitis
treatment
allergic rhinitis
epinastin
Prior art date
Application number
YUP-336/02A
Other languages
English (en)
Inventor
Gerold Duschler
Volker Trach
Original Assignee
Boehringer Ingelheim International Gmbh.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7928843&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RS50173(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim International Gmbh., filed Critical Boehringer Ingelheim International Gmbh.,
Priority to MEP-367/08A priority Critical patent/MEP36708A/xx
Publication of YU33602A publication Critical patent/YU33602A/sh
Publication of RS50173B publication Critical patent/RS50173B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F01—MACHINES OR ENGINES IN GENERAL; ENGINE PLANTS IN GENERAL; STEAM ENGINES
    • F01L—CYCLICALLY OPERATING VALVES FOR MACHINES OR ENGINES
    • F01L9/00—Valve-gear or valve arrangements actuated non-mechanically
    • F01L9/20—Valve-gear or valve arrangements actuated non-mechanically by electric means
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T137/00—Fluid handling
    • Y10T137/0318—Processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Mechanical Engineering (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Detergent Compositions (AREA)

Abstract

Primena rastvora koji se sastoji od: a) epinastina kao aktivna supstanca, opciono u obliku svog racemata, svojih enantiomera, i opciono u obliku svojih farmakološki prihvatljivih adicionih soli, u koncentraciji od 0.0005 do 0.1 mas.%, b) vode ili fiziološki slanog rasvora kao rastvarača, c) pufera za podešavanje pH na vrednost od 6.5 do 7.2, opciono dodavanjem natrijum hidroksida, d) konzervansa, i opciono e) helatnog agensa, f) viskoznog agensa, g) pojačivača penetracije h) antioksidanasa i) i/ili fiziološki prihvatljivih agenasa za podešavanje toničnosti rastvora, za pripremu medikamenta za topičnu primenu na vežnjači oka ili sluzokoži nosa za lečenje zakasnele fazne reakcije kod alergijskog rinitisa ili konjuktivitisa. Prijava sadrži još 11 zavisnih patentnih zahteva.
YUP-336/02A 1999-11-12 2000-10-14 Upotreba epinastina za lečenje alergijskog rinitisa/konjuktivitisa RS50173B (sr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MEP-367/08A MEP36708A (en) 1999-11-12 2000-10-14 Solutions containing epinastine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19954516A DE19954516A1 (de) 1999-11-12 1999-11-12 Epinastin-haltige Lösungen

Publications (2)

Publication Number Publication Date
YU33602A YU33602A (sh) 2005-03-15
RS50173B true RS50173B (sr) 2009-05-06

Family

ID=7928843

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-336/02A RS50173B (sr) 1999-11-12 2000-10-14 Upotreba epinastina za lečenje alergijskog rinitisa/konjuktivitisa

Country Status (40)

Country Link
US (6) US20030050303A1 (sr)
EP (1) EP1231920B1 (sr)
JP (1) JP2003514021A (sr)
KR (1) KR100758842B1 (sr)
CN (1) CN1292752C (sr)
AR (1) AR026424A1 (sr)
AT (1) ATE353218T1 (sr)
AU (2) AU784017B2 (sr)
BG (1) BG65775B1 (sr)
BR (1) BR0015477A (sr)
CA (1) CA2391076C (sr)
CO (1) CO5251448A1 (sr)
CY (1) CY1106375T1 (sr)
CZ (1) CZ302483B6 (sr)
DE (2) DE19954516A1 (sr)
DK (1) DK1231920T3 (sr)
EA (1) EA006937B1 (sr)
EE (1) EE05395B1 (sr)
ES (1) ES2281359T3 (sr)
HK (1) HK1052303B (sr)
HR (1) HRP20020404B1 (sr)
HU (1) HU229502B1 (sr)
IL (2) IL149501A0 (sr)
ME (1) MEP36708A (sr)
MX (1) MXPA02004556A (sr)
MY (1) MY130441A (sr)
NO (1) NO329417B1 (sr)
NZ (1) NZ519425A (sr)
PE (1) PE20010826A1 (sr)
PL (1) PL198879B1 (sr)
PT (1) PT1231920E (sr)
RS (1) RS50173B (sr)
SA (1) SA01210658B1 (sr)
SI (1) SI1231920T1 (sr)
SK (1) SK287343B6 (sr)
TR (1) TR200201270T2 (sr)
TW (1) TWI225401B (sr)
UA (1) UA74563C2 (sr)
WO (1) WO2001035962A1 (sr)
ZA (1) ZA200203683B (sr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
EP1531802A1 (en) * 2002-08-02 2005-05-25 Boehringer Ingelheim International GmbH Pharmaceutical formulations comprising combinations of epinastine, pseudoephedrine and methylephedrine
US20040247686A1 (en) * 2003-04-04 2004-12-09 Boehringer Ingelheim International Gmbh Pharmaceutical compositions comprising epinastine for the treatment of skin diseases
EP1468696A1 (en) * 2003-04-17 2004-10-20 Boehringer Ingelheim International GmbH Combinations of epinastine and antiphlogisitcs as new pharmaceutical compositions for the treatment of skin diseases
US20060073172A1 (en) * 2004-10-01 2006-04-06 Schneider L W Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure
WO2007007851A1 (en) * 2005-07-08 2007-01-18 Senju Pharmaceutical Co., Ltd. Percutaneously absorptive ophthalmic preparation comprising epinastine
WO2008098122A2 (en) * 2007-02-08 2008-08-14 Inspire Pharmaceuticals, Inc. Method for treating allergic rhinitis without adverse effects
US7378082B1 (en) 2007-11-05 2008-05-27 Inspire Pharmaceuticals, Inc. Method for treating allergic rhinitis without adverse effects
US20080194544A1 (en) * 2007-02-08 2008-08-14 Ramesh Krishnamoorthy Aqueous formulations of epinastine for treating allergic rhinitis
US20120203161A1 (en) * 2009-08-12 2012-08-09 Seros Medical, Llc Deuterated water and riboflavin solution for extending singlet oxygen lifetimes in treatment of ocular tissue and method of use
TWI544922B (zh) 2011-05-19 2016-08-11 愛爾康研究有限公司 高濃度歐羅派特錠（ｏｌｏｐａｔａｄｉｎｅ）眼用組成物
EP2630952A1 (en) * 2012-02-23 2013-08-28 Novagali Pharma S.A. Self-preserved oil dispersions comprising boric acid
US11058677B2 (en) * 2012-12-19 2021-07-13 Novartis Ag LFA-1 inhibitor formulations
CN104491876A (zh) * 2014-12-23 2015-04-08 中国药科大学 含玻璃酸钠的依匹斯汀滴眼液及其制备方法
ITUB20153950A1 (it) * 2015-09-28 2017-03-28 Tred Srl Dispositivo nasale in grado di attivare il riflesso rino-palatale per l'igienizzazione rinofaringea
JP6134853B1 (ja) * 2016-10-28 2017-05-24 参天製薬株式会社 エピナスチン含有点眼液
JP6635974B2 (ja) * 2017-04-24 2020-01-29 参天製薬株式会社 エピナスチン含有点眼液
KR20250026365A (ko) * 2017-05-01 2025-02-25 산텐 세이야꾸 가부시키가이샤 점안제
JP2019108320A (ja) * 2018-10-31 2019-07-04 参天製薬株式会社 ソフトコンタクトレンズの変質を抑制する眼科用組成物
JP7599838B2 (ja) * 2019-04-10 2024-12-16 参天製薬株式会社 エピナスチン又はその塩を含有する水性医薬組成物
JP6736752B2 (ja) * 2019-12-17 2020-08-05 参天製薬株式会社 エピナスチン含有点眼液
JP6963651B2 (ja) * 2020-04-16 2021-11-10 参天製薬株式会社 エピナスチン又はその塩を含有する水性組成物
JP7118579B1 (ja) 2020-04-16 2022-08-16 参天製薬株式会社 エピナスチン又はその塩を含有する水性組成物
JP2020169213A (ja) * 2020-07-15 2020-10-15 参天製薬株式会社 エピナスチン含有点眼液
JP7114668B2 (ja) * 2020-10-08 2022-08-08 参天製薬株式会社 エピナスチン又はその塩を含有する花粉破裂抑制剤
CN115448927A (zh) * 2022-10-20 2022-12-09 重庆瑞泊莱医药科技有限公司 一种氢溴酸依匹斯汀晶型ii及其制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US228359A (en) * 1880-06-01 jones
US104017A (en) * 1870-06-07 Improvement in embroidering attachment for sewing-machines
US215396A (en) * 1879-05-13 Improvement in loom-temples
US151541A (en) * 1874-06-02 Improvement in hay-loaders
US203021A (en) * 1878-04-30 Improvement in side-bar wagons
US8632A (en) * 1852-01-06 George hess
US181478A (en) * 1876-08-22 Improvement in water-wheels
DE3008944A1 (de) * 1980-03-08 1981-09-24 C.H. Boehringer Sohn, 6507 Ingelheim Dibenzimidazoazepine, ihre herstellung und verwendung
DE4102148A1 (de) * 1991-01-25 1992-07-30 Boehringer Ingelheim Kg Verfahren zur herstellung von 3-amino-9,13b-dihydro-1h-dibenz-(c,f)imidazol(1,5-a)azepin-hydrochlorid
US5668133A (en) * 1992-12-09 1997-09-16 Alcon Laboratories, Inc. Ophthalmic compositions comprising emedastine and methods for their use
NZ312662A (en) * 1995-06-27 2001-03-30 Boehringer Ingelheim Kg Pharmaceutical aerosol preparations in the form of stable ethanolic solutions of active substances for producing propellant free aerosols
DE19542281C2 (de) * 1995-11-14 1997-12-04 Boehringer Ingelheim Kg Verwendung von Epinastin für die Behandlung der Migräne
WO1998008504A1 (en) * 1996-08-30 1998-03-05 Kyoto Pharmaceutical Industries, Ltd. Remedies for allergic dermatitis
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
US20030215396A1 (en) * 1999-09-15 2003-11-20 Boehringer Ingelheim Pharma Kg Method for the production of propellant gas-free aerosols from aqueous medicament preparations
EP0903151A1 (en) * 1997-09-22 1999-03-24 ASTA Medica Aktiengesellschaft Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
PL355101A1 (en) * 1999-11-18 2004-04-05 Alcon Inc. Use of h1
DE19958460A1 (de) * 1999-12-03 2001-06-07 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Epinastine-Hydrochlorid in der hochschmelzenden Kristallmodifikation
FR2803520B1 (fr) * 2000-01-12 2002-09-20 Ceva Sante Animale Procede pour augmenter la production d'oeufs et consolider la coquille des oeufs chez les volailles
US20020094345A1 (en) * 2000-10-06 2002-07-18 Sara Abelaira Pharmaceutical compositions containing epinastine and pseudoephedrine
US20020137764A1 (en) * 2000-10-31 2002-09-26 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt
US20020151541A1 (en) * 2000-10-31 2002-10-17 Michel Pairet Pharmaceutical compositions containing tiotropium salts and antihistamines and their use
DE10119718A1 (de) * 2001-04-21 2002-10-31 Boehringer Ingelheim Pharma Verfahren zur kontinuierlichen Herstellung inhalierfähiger Arzneistoffe, Vorrichtung zur Durchführung des Verfahrens und nach diesem Verfahren hergestellter Arzneistoff
AU2002305780A1 (en) * 2001-05-29 2002-12-09 Transchip, Inc. Patent application cmos imager for cellular applications and methods of using such
US20030104017A1 (en) * 2001-10-26 2003-06-05 Boehringer Ingelheim International Gmbh Epinastine formulation for oral administration
EP1350512A1 (en) * 2002-04-03 2003-10-08 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Combinations of epinastine, belladonna and pseudoephedrine as new pharmaceutical formulations
US6863848B2 (en) * 2002-08-30 2005-03-08 Signet Armorlite, Inc. Methods for preparing composite photochromic ophthalmic lenses
JP2007145316A (ja) * 2005-10-27 2007-06-14 Nissan Motor Co Ltd 遮光装置とサンバイザーとサンルーフユニット

Also Published As

Publication number Publication date
AR026424A1 (es) 2003-02-12
EA200200492A1 (ru) 2002-10-31
US20090239842A1 (en) 2009-09-24
EE05395B1 (et) 2011-04-15
US20050288274A1 (en) 2005-12-29
ES2281359T3 (es) 2007-10-01
EA006937B1 (ru) 2006-06-30
UA74563C2 (uk) 2006-01-16
HU229502B1 (en) 2014-01-28
US20030050303A1 (en) 2003-03-13
NO329417B1 (no) 2010-10-18
MXPA02004556A (es) 2004-09-10
US20070197503A1 (en) 2007-08-23
DE19954516A1 (de) 2001-05-17
AU2006201541A1 (en) 2006-05-11
KR20020050273A (ko) 2002-06-26
KR100758842B1 (ko) 2007-09-19
SI1231920T1 (sl) 2007-06-30
AU1138101A (en) 2001-05-30
US20070185082A1 (en) 2007-08-09
MEP36708A (en) 2011-02-10
HRP20020404A2 (en) 2004-08-31
HUP0203773A2 (hu) 2003-03-28
ZA200203683B (en) 2003-09-03
JP2003514021A (ja) 2003-04-15
CZ20021956A3 (cs) 2002-08-14
DE50014041D1 (de) 2007-03-22
HRP20020404B1 (hr) 2007-08-31
TR200201270T2 (tr) 2002-12-23
NZ519425A (en) 2004-04-30
SA01210658B1 (ar) 2006-11-05
CZ302483B6 (cs) 2011-06-08
WO2001035962A1 (de) 2001-05-25
IL149501A (en) 2012-04-30
IL149501A0 (en) 2002-11-10
PL198879B1 (pl) 2008-07-31
PL364028A1 (en) 2004-11-29
EP1231920A1 (de) 2002-08-21
HK1052303B (zh) 2007-04-13
PE20010826A1 (es) 2001-08-20
CO5251448A1 (es) 2003-02-28
EP1231920B1 (de) 2007-02-07
CN1390129A (zh) 2003-01-08
HUP0203773A3 (en) 2005-01-28
DK1231920T3 (da) 2007-04-10
AU784017B2 (en) 2006-01-12
SK8302002A3 (en) 2002-09-10
US20080009476A1 (en) 2008-01-10
BG65775B1 (bg) 2009-11-30
CA2391076C (en) 2008-06-17
CA2391076A1 (en) 2001-05-25
MY130441A (en) 2007-06-29
BG106681A (en) 2002-12-29
PT1231920E (pt) 2007-03-30
NO20022201D0 (no) 2002-05-08
TWI225401B (en) 2004-12-21
NO20022201L (no) 2002-05-08
CY1106375T1 (el) 2011-10-12
US7429602B2 (en) 2008-09-30
EE200200246A (et) 2003-06-16
ATE353218T1 (de) 2007-02-15
CN1292752C (zh) 2007-01-03
SK287343B6 (sk) 2010-07-07
YU33602A (sh) 2005-03-15
HK1052303A1 (en) 2003-09-11
BR0015477A (pt) 2002-06-25

Similar Documents

Publication Publication Date Title
RS50173B (sr) Upotreba epinastina za lečenje alergijskog rinitisa/konjuktivitisa
DK1697370T3 (da) Azabicykliske heterocykliske forbindelser som cannabinoidreceptormodulatorer
CO5271759A1 (es) Formulacion en solucion que contiene una mezcla de disolventes
MEP33708A (hr) Farmaceutske smješe koje obuhvataju inhibitor hmg coa reduktaze
ES2295609T3 (es) Derivados de tiadiazolilpiperazina utiles para tratar o prevenir un dolor.
ES2063146T3 (es) Composiciones farmaceuticas que contienen acido n-(3,4-dimetoxicinamoil)-antranilico.
RS54050B1 (sr) Formulacije i metode za lečenje amiloidoze
BR0012175A (pt) Antagonistas de receptor de igiur5, seletivos para o tratamento de enxaqueca
ATE526955T1 (de) Konzentrierte zusammensetzung für topische anwendung am huf
RU2002117649A (ru) Фармацевтические композиции, содержащие золмитриптан
BR0012951A (pt) Agonistas de retinóides seletivos
IT1305306B1 (it) Uso della pirenoxina per la protezione dei tessuti corneali ininterventi di fotocheratectomia.
BR0116060A (pt) Composição farmacêutica de dronedarona para administração parenteral
RS51041B (sr) Tečne formulacije tbp-1 proteina koji vezuju faktor tumorske nekroze
DK1343472T3 (da) Thixotropisk næsespray
JP4849288B2 (ja) 点眼剤及び涙液膜の安定化剤
BR9916320A (pt) Bisamido polibiguanidas e uso das mesmas para desinfetar lentes de contato e preservar composições farmacêuticas
BR0015423A (pt) Análogos de ácido 15-hidroxieicosatetraenóico interrompidos por heteroátomo e métodos de uso
ES2197781B1 (es) Composiciones farmaceuticas liquidas de base acuosa en forma de suspension para la administracion por via oral de ibuprofeno.
BR0013651A (pt) Tratamento de enxaqueca pela administração de ácido alfalipóico ou seus derivados
NO975726L (no) N-Hydroksyurea-derivater som anti-inflammatoriske midler
PE20041022A1 (es) Formulaciones farmaceuticas que comprenden un nuevo agente enmascarante de la amargura
SE9900190D0 (sv) New compounds
DE60135845D1 (de) Pralmorelin-haltige nasentropfen-präparate
MEP39708A (en) New pharmaceutical compositions containing epinastine and pseudoephedrine